Register Login

All Posts

ISTH Covid Antithrombotics Guidelines

On Wednesday, 8-3-22, the ISTH published comprehensive guidelines recommending for or against antithrombotic agents for Covid at defined levels of severity. Below are the task force guidelines and an editorial describing the research considerations behind guideline development. Schulman S, Sholzberg M, Spyropoulos AC, et al. ISTH guidelines for antithrombotic treatment in COVID-19. JTH 2022, DOI: […]
read more

July 2022 QQ: Reduced concentration RIPA test.

Our July 2022 Quick Question asks, “What von Willebrand disease [VWD] subtype is identified using the reduced concentration ristocetin-induced platelet aggregometry [RIPA] test?” Many of the VWD types and subtypes are currently identified using molecular diagnosis, however, the “legacy” phenotypic tests often provide a speedy and inexpensive shortcut. This may be one such case. Please […]
read more